Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 757-768 of 4,306
Drug study icon
Not recruitingISRCTN96331501

A study on the therapeutic effect of modified electroconvulsive therapy in refractory schizophrenia

This study is testing a medication approach for people with Treatment-resistant schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In China
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
China
Sponsor
Wuhan Wudong Hospital
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN10534853

A study to investigate the safety and processing by the body of the drug AUT00206 in people with schizophrenia, and to explore the effects of AUT00206 on relevant central biomarkers

This study is not recruiting in the United Kingdom. It focuses on schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Autifony Therapeutics (United Kingdom)
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN31248612

Arachidonic acid supplementation to improve cognitive impairment of schizophrenia

This study is looking at a support or therapy approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.

In China
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
China
Sponsor
National Natural Science Foundation of China
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN59055607

Cognitive Behavioural Therapy for psychosis (CBTp) in acute mental health inpatient settings

This study is looking at how cognitive behavioural therapy works for people with Acute mental health inpatient service users experiencing psychosis, Mental and Behavioural Disorders, or Psychosis, schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, or psychosis not otherwise specified in routine care. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
University College London
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN84216587

Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Queen Mary University of London and Barts and the London NHS Trust (UK)
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN15399617

Improving the continuity of care for schizophrenia

This study is not recruiting in Germany. It is testing improving the continuity of care for schizophrenia.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
Germany
Sponsor
University Hospital Heidelberg Center for Psychotherapy Research
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN61129760

Liraglutide and the management of overweight and obesity in people with schizophrenia

This study is looking at care and outcomes for people with Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia, schizotypal and delusional disorders. Direct benefit is not guaranteed, but the study may help researchers improve future care.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United Kingdom
Sponsor
Southern Health NHS Foundation Trust
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN12245577

Niacin skin flushing response in evaluating the efficacy of modified electroconvulsive therapy in schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In China
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
The Fourth People's Hospital of Wuhu
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN32434568

OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Finland, Italy
Sponsor
University of Oxford (UK)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN61441186

Open, study of the effect of aripiprazole versus risperidone on social cognition in schizophrenia

This study is not recruiting in the Netherlands. It is testing open, randomised trial of the effect of aripiprazole versus risperidone on social cognition for schizophrenia.

In Netherlands
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Centre Utrecht (UMCU) (The Netherlands)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.